Nova Patents
LUC00331I2

Treating breast cancer using selective estrogen receptor modulators

Abstract

This record has no abstract on file.

Term

17.4 yearsto projected expiry

Projected expiry 29 February 2044, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

58 members in 20 offices

This recordMember, by publication datePriority claim10 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
201461971627United States of AmericaP
201562129379United States of AmericaP

Members58

Family members, oldest first
DocumentOfficeKind
CA2943611A1CanadaA1
US2015274640A1United States of AmericaA1
WO2015149045A1World Intellectual Property Organization (WIPO)A1
US9421264B2United States of AmericaB2
US2016324808A1United States of AmericaA1
EP3122426A1European Patent Office (EPO)A1
US2017202823A1United States of AmericaA1
EP3122426A4European Patent Office (EPO)A4
US10071066B2United States of AmericaB2
US2019083421A1United States of AmericaA1
US10420734B2United States of AmericaB2
US2020009084A1United States of AmericaA1
US2020121621A1United States of AmericaA1
US2020368184A1United States of AmericaA1
EP3834824A1European Patent Office (EPO)A1
US2022110893A1United States of AmericaA1
EP4035664A2European Patent Office (EPO)A2
EP4035664A3European Patent Office (EPO)A3
EP3122426B1European Patent Office (EPO)B1
PT3122426TPortugalT
LT3122426TLithuaniaT
FI3122426T3FinlandT3
DK3122426T3DenmarkT3
US2023131271A1United States of AmericaA1
ES2939940T3SpainT3
RS64115B1SerbiaB1
SI3122426T1SloveniaT1
SMT202300072T1San MarinoT1
PL3122426T3PolandT3
HRP20230365T1CroatiaT1
HUE061499T2HungaryT2
US11779552B2United States of AmericaB2
US2023398085A1United States of AmericaA1
NO2024007I1NorwayI1
FIC20240005I1FinlandI1
LTPA2024504I1LithuaniaI1
HUS2400002I1HungaryI1
US11951080B2United States of AmericaB2
FR24C1007I1FranceI1
US2024197654A1United States of AmericaA1
NL301263I2Netherlands (Kingdom of the)I2
CY1125821T1CyprusT1
CY2024004I1CyprusI1
CY2024004I2CyprusI2
US12263142B2United States of AmericaB2
US2025205180A1United States of AmericaA1
EP3834824B1European Patent Office (EPO)B1
PT3834824TPortugalT
DK3834824T3DenmarkT3
FI3834824T3FinlandT3
LT3834824TLithuaniaT
RS67458B1SerbiaB1
HRP20251500T1CroatiaT1
US20260007620A1United States of AmericaA1
SMT202500448T1San MarinoT1
SI3834824T1SloveniaT1
ES3055185T3SpainT3
LUC00331I2This recordLuxembourgI2